Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation 2024-09-05 20:00
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration 2024-09-05 13:49
Grand launch | Sanyou Bio monkeypox antibody made a great breakthrough 2024-09-05 08:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
HKBU develops Chinese medicine for ulcerative colitis approved by National Medical Products Administration for clinical trial 2024-09-04 15:13
Biostar Announces Completion of Patient Recruitment for US Phase 1 Clinical Study of Utidelone Capsule 2024-09-03 20:00
Skyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa 2024-09-03 18:00
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
Caliway Announces the Initiation of Subject Recruitment in CBL-514 Phase 2b Study for Dercum's Disease 2024-09-03 15:18
Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor 2024-09-02 20:24
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China 2024-08-30 19:34
Breaking News | Sanyou Bio Launches Comprehensive Monkeypox Product Line 2024-08-30 18:00
CARsgen® Announces 2024 Interim Results 2024-08-29 20:50
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results 2024-08-29 14:31
Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization 2024-08-29 04:20
Asieris Pharmaceuticals Releases 2024 Semi-Annual Report, Highlighting Steady Progress in Launching Blockbuster Product for Precancerous Cervical Lesions and Continued Strengthening of Commercial Revenue Generation Capabilities 2024-08-28 21:34
Tigermed Reports 2024 Interim Results 2024-08-28 18:26
Fosun Pharma Announces 2024 Interim Results 2024-08-28 18:10
Harbour BioMed Announces 2024 Interim Results 2024-08-28 17:44
Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization 2024-08-28 17:29
1 7 8 9 10 11 165